Wimmer Associates 1’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
2,269
+3
| +0.1% | +$2.34K | 0.9% | 29 |
|
|
2025
Q1 | $1.69M | Buy |
2,266
+66
| +3% | +$49.2K | 0.89% | 29 |
|
|
2024
Q4 | $1.7M | Buy |
2,200
+815
| +59% | +$629K | 0.84% | 29 |
|
|
2024
Q3 | $1.23M | Sell |
1,385
-7
| -0.5% | -$6.2K | 0.6% | 40 |
|
|
2024
Q2 | $1.26M | Buy |
1,392
+25
| +2% | +$22.6K | 0.65% | 40 |
|
|
2024
Q1 | $1.06M | Hold |
1,367
| – | – | 0.56% | 47 |
|
|
2023
Q4 | $797K | Sell |
1,367
-28
| -2% | -$16.3K | 0.45% | 52 |
|
|
2023
Q3 | $749K | Buy |
1,395
+110
| +9% | +$59.1K | 0.47% | 52 |
|
|
2023
Q2 | $603K | Hold |
1,285
| – | – | 0.36% | 66 |
|
|
2023
Q1 | $558K | Buy |
1,285
+85
| +7% | +$36.9K | 0.36% | 70 |
|
|
2022
Q4 | $439K | Sell |
1,200
-40
| -3% | -$14.6K | 0.29% | 80 |
|
|
2022
Q3 | $449K | Sell |
1,240
-5
| -0.4% | -$1.81K | 0.3% | 79 |
|
|
2022
Q2 | $404K | Buy |
1,245
+45
| +4% | +$14.6K | 0.26% | 81 |
|
|
2022
Q1 | $344K | Sell |
1,200
-210
| -15% | -$60.2K | 0.19% | 93 |
|
|
2021
Q4 | $389K | Hold |
1,410
| – | – | 0.21% | 90 |
|
|
2021
Q3 | $326K | Hold |
1,410
| – | – | 0.19% | 96 |
|
|
2021
Q2 | $324K | Hold |
1,410
| – | – | 0.19% | 97 |
|
|
2021
Q1 | $263K | Buy |
1,410
+55
| +4% | +$10.3K | 0.14% | 100 |
|
|
2020
Q4 | $229K | Hold |
1,355
| – | – | 0.14% | 107 |
|
|
2020
Q3 | $201K | Buy |
+1,355
| New | +$201K | 0.14% | 104 |
|